Ictus isquémico en pacientes con estenosis carotídea asintomática de alto grado
Description
La estenosis carotídea asintomática de alto grado representa un reto terapéutico. La decisión entre el manejo médico y quirúrgico exige una valoración cuidadosa del riesgo - beneficio. Se presenta un estudio poblacional en el que se analizó la incidencia de ictus isquémico durante un periodo de seguimiento de 4,1 años, que resultó del 4,7%. Este riesgo fue bajo en comparación con series previas, si bien se encontró una tasa de mortalidad elevada. Estos datos pueden contribuir a la toma de decisiones en pacientes con estenosis carotídea asintomática de alto grado.
Asymptomatic high-grade carotid stenosis represents a therapeutic challenge. The decision between medical and surgical management requires a careful risk-benefit assessment. We present a population study in which the incidence of ischemic stroke was analyzed during a follow-up period of 4.1 years, which was 4.7%. This risk was low compared to previous series, although a high mortality rate was found. These data may contribute to decision-making in patients with asymptomatic highgrade carotid stenosis.
Files
Journal 60 - 10.pdf
Additional details
References
- Vol 59 N4; págs. 956-967. 2014. Kakkos SK, Nicolaides AN, Charalambous I, Thomas D, Giannopoulos A, Naylor AR, et al. Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. Journal of Vascular Surgery. Doi: https://doi.org/10.1016/j.jvs.2013.10.073
- Vol 8 N19; pág 1271. 2020. Paraskevas KI, Nicolaides AN, Kakkos SK. Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) study: what have we learned from it? Annals of Translational Medicine. Doi: https://doi.org/10.21037/atm.2020.02.156
- Vol 376 N9746; págs. 1074-1084. 2010. Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. The Lancet. Doi: https://doi.org/10.1016/s0140-6736(10)61197-x
- Vol 376 N9746; págs. 1074-1084. 2010. Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. The Lancet. Doi: https://doi.org/10.1016/s0140-6736(10)61197-x
- Vol 31 N13-14; págs.1711-1717. 2017. Rodolfo Pini, Gianluca Faggioli, Andrea Vacirca, Laura Maria Cacioppa,Enrico Gallitto,Mauro Gargiulo & Andrea Stella. The fate of asymptomatic severe carotid stenosis in the era of best medical therapy. Brain Injury. Doi: https://doi.org/10.1080/02699052.2017.1346285
- Vol 111 N5; págs. 970-7. 2009. Nagaki T, Sato K, Yoshida T, Yoshimoto Y. Benefit of carotid endarterectomy for symptomatic and asymptomatic severe carotid artery stenosis: a Markov model based on data from randomized controlled trials: Clinical article. JNS Journal of Neurosurgery. Doi: https://doi.org/10.3171/2009.4.jns08568
- Vol 20 N3; págs. 193-202. 2021. Howard DPJ, Gaziano L, Rothwell PM. Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis. The Lancet Neurology. Doi: https://doi.org/10.1016/s1474-4422(20)30484-1
- Vol 74 N6; págs. 1937-1947. 2021. Robert W. Chang, MD, Lue-Yen Tucker, BA, Kara A. Rothenberg, MD, Elizabeth M. Lancaster, MD, Andrew L. Avins, MD, Hui C. Kuang, NP, et al. Establishing a carotid artery stenosis disease cohort for comparative effectiveness research using natural language processing. Journal of Vascular Surgery Surg. Doi: https://doi.org/10.1016/j.jvs.2021.05.054